Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
dexamethasone sodium phosphate + isopropyl alcohol + povidone-iodine + lidocaine
- Development stage
- Unknown
- Lead developer
- Enovachem
- Modality
- Small Molecules
- Administration
- Intravenous, Intramuscular, Topical, Parenteral
01
Overview
Dexlido is a combination pharmaceutical kit containing **dexamethasone sodium phosphate**, **lidocaine**, **povidone-iodine**, and **isopropyl alcohol**. The therapeutically active systemic component is dexamethasone sodium phosphate, a water-soluble synthetic corticosteroid small molecule that acts primarily as a **glucocorticoid receptor agonist** to produce anti-inflammatory and immunosuppressive effects after parenteral administration. Lidocaine is included as a local anesthetic to reduce injection-site pain, while povidone-iodine and isopropyl alcohol function as topical antiseptic skin-preparation components used with administration of the injectable product. The kit has been distributed by Enovachem Pharmaceuticals for use across a broad set of labeled corticosteroid-responsive conditions when intravenous or intramuscular therapy is needed, but it has been described as an unapproved drug product whose labeling has not been approved by the FDA.
- Brand names
- Dexlido
- Other names
- dexamethasone sodium phosphate + isopropyl alcohol + povidone-iodine + lidocaine
02
Targets
GR (Glucocorticoid receptor)NaV alpha (Voltage-gated sodium channel alpha subunit family)
Beyond the preview
Go deeper on dexamethasone sodium phosphate + isopropyl alcohol + povidone-iodine + lidocaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on dexamethasone sodium phosphate + isopropyl alcohol + povidone-iodine + lidocaine.